Medincell receives $19m grant for mdc-WWM programme

This article was originally published here

It aims to fund preclinical activities and a phase 1 clinical trial for the injectable six-month bioresorbable contraceptive (mdc-WWM). The grant is structured in advanced installments to cover

The post Medincell receives $19m grant for mdc-WWM programme appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply